A group of shareholders owning 10 per cent of Nasdaq listed Bray medical firm Trinity Biotech has warned it will take its case to the Office of the Director of Corporate Enforcement (ODCE) in a row over its attempts to requisition a shareholder meeting and oust the company’s board.
The shareholder group, headed by Kansas-based investor Tom Reidy, a former executive in a Trinity subsidiary, said it was considering making a formal complaint to...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team